Publication | Closed Access
Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways
77
Citations
29
References
2019
Year
InflammationSignal TransductionMedicineDiabetesGinsenoside Rg1Streptozotocin-induced Type 1Diabetes MellitusPharmacologyCell BiologyCell SignalingKeap1/nrf2/ho-1 PathwaysOxidative StressInsulin Signaling
| Year | Citations | |
|---|---|---|
Page 1
Page 1